Work Productivity Loss Due To Rheumatoid Arthtiris (Ra), Crohn's Disease (Cd) And Psoriasis (Ps) In Poland.

The immune-mediated inflammatory diseases (IMIDs) influence physical and mental state of the patients. Additionally, they affect greatly work productivity, not only by eliminating patients in productive age from the working population, but also influencing every-day work performance. The productivity loss, which is significant from the individual’s perspective, can also be measured globally as a loss of benefit for the whole society. It could be expected that loss of productivity rises with severity of patient’s condition. In case of autoimmune inflammatory diseases, it could be related to the severity of the inflammation episode. That is why it is important to control the intensity of episodes to minimize the productivity loss. The analysis of total indirect cost of a disease should be an important factor taken into consideration by health care policy makers. The aim of this presentation was to demonstrate the total indirect costs of RA, CD and Ps in an employed population in Poland and to show how differently indirect costs (namely costs of absenteeism and presenteeism) can be generated by each disease.